TradingView
RocketTickers
24 сен 2018 г., 17:13
AnaptysBio Reports Positive Topline Data from Phase 2a
Длинная
NASDAQ:ANAB
AnaptysBio, Inc.
NASDAQ
Описание
⋅
24 сен 2018 г., 17:13
ANAB: AnaptysBio, Inc.
2018-09-24 06:30:00
AnaptysBio Reports Positive Topline Data from Phase 2a Proof-of-Concept Clinical Trial of Etokimab in Severe Eosinophilic Asthma
Beyond Technical Analysis
Ещё